Skip to content
Open access

Evaluating the Relationship Between Early Non‐Motor Symptoms and Late Diagnosis of Parkinson's Disease Based on the PPMI Database From 2012 to 2018: A Retrospective Cross‐Sectional Study

Aug 2026 · Health Science Reports · Vol 9 · 0 citations · 34 references
Medicine

TL;DR

Socio‐demographic variables, rather than individual non‐motor symptoms, demonstrate the strongest independent associations with diagnostic timing in this cohort, highlighting the need for socio‐demographically tailored screening strategies in the prodromal phase of PD.

Abstract

Parkinson's (PD) diagnosis is frequently delayed, particularly when patients present with non‐motor symptoms (NMS). This study evaluates the association between NMS, socio‐demographic factors, and diagnostic timing in PD using PPMI data. We aimed to determine how clinical and demographic profiles influence the interval between NMS onset and clinical diagnosis, acknowledging that this interval reflects both biological disease progression and healthcare‐related factors.

Read PDF

Similar papers

Open access Aug 2026

Development and validation of a multimodal nomogram predicting anxiety and depression in Parkinson’s disease: integrating plasma biomarkers and clinical phenotypes

Combining peripheral plasma NfL levels with standard clinical phenotypes provides an objective, quantifiable, and non-invasive tool for early risk stratification of affective disorders in PD.

Guidong Liu, Yan-Qin Geng, Hanwen Zhang et al. · 0 citations
Open access Jul 2026

Association between the prognostic nutritional index and impulse control disorders in patients with early-stage Parkinson's disease

Background Impulse control disorders (ICDs) are common non-motor symptoms in Parkinson's disease (PD) and associated with significant psychiatric morbidity and reduced quality of life. The prognostic nutritional index (PNI) reflects both nutritional and immune status. However, the relationship between PNI and ICDs in e...

Wen Zhou, Jiaojiao Shi, Duan Liu et al. · 0 citations
Open access Aug 2026

Progression to Dementia in Very Late‐Onset Schizophrenia‐Like Psychosis Stratified by Alzheimer's Disease and Lewy Body Disease Biomarkers: A Retrospective Cohort Study

AD and/or LBD biomarker‐positive VLOSLP may be associated with greater dementia progression and cognitive decline, although findings should be interpreted cautiously given the small sample size and retrospective design.

Y. Satake, H. Kanemoto, Daiki Taomoto et al. · 0 citations
Open access Jul 2026

Disease‐Duration–Specific Percentiles for Prospective Subtyping of Parkinson's Disease: A PPMI‐Based Study

It is established that disease duration–specific percentiles for prospective application of the DM/IM/MMP subtyping model is established, supporting patient stratification and enrichment in disease‐modifying trials.

Ahmed Negida, Nitai D. Mukhopadhyay, Brian D Berman et al. · 0 citations
Open access Jul 2026

The Vall d’Hebron Initiative for Parkinson (VHIP) cohort: a prospective, longitudinal, and observational study enrolling de novo Parkinson’s disease patients for biomarker identification and validation

VHIP is the first study to establish a Spanish cohort combining clinical, imaging, biochemical and molecular data over time in de novo patients, including PD-linked mutation carriers, including carriers of PD-linked mutations.

Daniela Samaniego, Silvia Enríquez-Calzada, L. Domingo et al. · 0 citations
Open access Aug 2026

Vascular Risk Factors and the Risk of Incident Parkinson’s Disease Among Stroke Survivors: A Nationwide Population-Based Cohort Study

It is suggested that several VRFs are associated with subsequent PD risk in stroke survivors and further studies are warranted to determine whether modification of these risk factors influences the development of PD.

S. Yoon, H. Moon, Jin-Hyung Jung et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.